Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives

Alicia M. Allen, Kim Lundeen, Lynn E. Eberly, Sharon S. Allen, Mustafa al'Absi, Myra Muramoto, Dorothy Hatsukami

Research output: Research - peer-reviewArticle

Abstract

Introduction While endogenous sex hormones influence smoking-related outcomes, little is known about the role of hormonal contraceptives (HCs). This is despite dated estimates suggesting that HC use is prevalent among female smokers. Therefore, we sought to update estimates of the prevalence of HC use among female smokers and explore the association of HC use with various smoking motives (SMs). Methods This online cross-sectional survey recruited female smokers between the ages of 18–35. Survey questions assessed smoking behavior, SMs, use of HCs, and menstrual cycle regularity. Results Participants (n = 734) were, on average (± standard deviation), 20.7 ± 2.7 years old and smoked 7.3 ± 6.7 cigarettes/day. The majority of females reported a history of HC use (85%) and half reported current use (48%). Cyclical HC users (n = 227) scored significantly lower on three SMs compared to naturally-cycling women in the follicular phase (n = 62) and significantly higher on 15 SMs compared to naturally-cycling women in the luteal phase (n = 29). Women on cyclical HCs differed from women on long-acting HCs (n = 128) on two SMs. Further, the naturally-cycling women in the follicular phase scoring significantly higher on 15 SMs compared to those in the luteal phase. Discussion These observations indicate that HC use remains prevalent in female smokers and may influence SMs. Additional research should replicate these observations and explore the implications on smoking cessation outcomes.

LanguageEnglish (US)
Pages187-192
Number of pages6
JournalAddictive Behaviors
Volume77
DOIs
StatePublished - Feb 1 2018

Fingerprint

Contraceptive Agents
Smoking
Follicular Phase
Luteal Phase
Reproductive History
Gonadal Steroid Hormones
Smoking Cessation
Menstrual Cycle
Tobacco Products
Cross-Sectional Studies
Research
Surveys and Questionnaires

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Toxicology
  • Psychiatry and Mental health

Cite this

Allen, A. M., Lundeen, K., Eberly, L. E., Allen, S. S., al'Absi, M., Muramoto, M., & Hatsukami, D. (2018). Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives. Addictive Behaviors, 77, 187-192. DOI: 10.1016/j.addbeh.2017.10.011

Hormonal contraceptive use in smokers : Prevalence of use and associations with smoking motives. / Allen, Alicia M.; Lundeen, Kim; Eberly, Lynn E.; Allen, Sharon S.; al'Absi, Mustafa; Muramoto, Myra; Hatsukami, Dorothy.

In: Addictive Behaviors, Vol. 77, 01.02.2018, p. 187-192.

Research output: Research - peer-reviewArticle

Allen, AM, Lundeen, K, Eberly, LE, Allen, SS, al'Absi, M, Muramoto, M & Hatsukami, D 2018, 'Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives' Addictive Behaviors, vol 77, pp. 187-192. DOI: 10.1016/j.addbeh.2017.10.011
Allen AM, Lundeen K, Eberly LE, Allen SS, al'Absi M, Muramoto M et al. Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives. Addictive Behaviors. 2018 Feb 1;77:187-192. Available from, DOI: 10.1016/j.addbeh.2017.10.011
Allen, Alicia M. ; Lundeen, Kim ; Eberly, Lynn E. ; Allen, Sharon S. ; al'Absi, Mustafa ; Muramoto, Myra ; Hatsukami, Dorothy. / Hormonal contraceptive use in smokers : Prevalence of use and associations with smoking motives. In: Addictive Behaviors. 2018 ; Vol. 77. pp. 187-192
@article{ea365290c2d8418889954ba047029d50,
title = "Hormonal contraceptive use in smokers: Prevalence of use and associations with smoking motives",
abstract = "Introduction While endogenous sex hormones influence smoking-related outcomes, little is known about the role of hormonal contraceptives (HCs). This is despite dated estimates suggesting that HC use is prevalent among female smokers. Therefore, we sought to update estimates of the prevalence of HC use among female smokers and explore the association of HC use with various smoking motives (SMs). Methods This online cross-sectional survey recruited female smokers between the ages of 18–35. Survey questions assessed smoking behavior, SMs, use of HCs, and menstrual cycle regularity. Results Participants (n = 734) were, on average (± standard deviation), 20.7 ± 2.7 years old and smoked 7.3 ± 6.7 cigarettes/day. The majority of females reported a history of HC use (85%) and half reported current use (48%). Cyclical HC users (n = 227) scored significantly lower on three SMs compared to naturally-cycling women in the follicular phase (n = 62) and significantly higher on 15 SMs compared to naturally-cycling women in the luteal phase (n = 29). Women on cyclical HCs differed from women on long-acting HCs (n = 128) on two SMs. Further, the naturally-cycling women in the follicular phase scoring significantly higher on 15 SMs compared to those in the luteal phase. Discussion These observations indicate that HC use remains prevalent in female smokers and may influence SMs. Additional research should replicate these observations and explore the implications on smoking cessation outcomes.",
author = "Allen, {Alicia M.} and Kim Lundeen and Eberly, {Lynn E.} and Allen, {Sharon S.} and Mustafa al'Absi and Myra Muramoto and Dorothy Hatsukami",
year = "2018",
month = "2",
doi = "10.1016/j.addbeh.2017.10.011",
volume = "77",
pages = "187--192",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Hormonal contraceptive use in smokers

T2 - Addictive Behaviors

AU - Allen,Alicia M.

AU - Lundeen,Kim

AU - Eberly,Lynn E.

AU - Allen,Sharon S.

AU - al'Absi,Mustafa

AU - Muramoto,Myra

AU - Hatsukami,Dorothy

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Introduction While endogenous sex hormones influence smoking-related outcomes, little is known about the role of hormonal contraceptives (HCs). This is despite dated estimates suggesting that HC use is prevalent among female smokers. Therefore, we sought to update estimates of the prevalence of HC use among female smokers and explore the association of HC use with various smoking motives (SMs). Methods This online cross-sectional survey recruited female smokers between the ages of 18–35. Survey questions assessed smoking behavior, SMs, use of HCs, and menstrual cycle regularity. Results Participants (n = 734) were, on average (± standard deviation), 20.7 ± 2.7 years old and smoked 7.3 ± 6.7 cigarettes/day. The majority of females reported a history of HC use (85%) and half reported current use (48%). Cyclical HC users (n = 227) scored significantly lower on three SMs compared to naturally-cycling women in the follicular phase (n = 62) and significantly higher on 15 SMs compared to naturally-cycling women in the luteal phase (n = 29). Women on cyclical HCs differed from women on long-acting HCs (n = 128) on two SMs. Further, the naturally-cycling women in the follicular phase scoring significantly higher on 15 SMs compared to those in the luteal phase. Discussion These observations indicate that HC use remains prevalent in female smokers and may influence SMs. Additional research should replicate these observations and explore the implications on smoking cessation outcomes.

AB - Introduction While endogenous sex hormones influence smoking-related outcomes, little is known about the role of hormonal contraceptives (HCs). This is despite dated estimates suggesting that HC use is prevalent among female smokers. Therefore, we sought to update estimates of the prevalence of HC use among female smokers and explore the association of HC use with various smoking motives (SMs). Methods This online cross-sectional survey recruited female smokers between the ages of 18–35. Survey questions assessed smoking behavior, SMs, use of HCs, and menstrual cycle regularity. Results Participants (n = 734) were, on average (± standard deviation), 20.7 ± 2.7 years old and smoked 7.3 ± 6.7 cigarettes/day. The majority of females reported a history of HC use (85%) and half reported current use (48%). Cyclical HC users (n = 227) scored significantly lower on three SMs compared to naturally-cycling women in the follicular phase (n = 62) and significantly higher on 15 SMs compared to naturally-cycling women in the luteal phase (n = 29). Women on cyclical HCs differed from women on long-acting HCs (n = 128) on two SMs. Further, the naturally-cycling women in the follicular phase scoring significantly higher on 15 SMs compared to those in the luteal phase. Discussion These observations indicate that HC use remains prevalent in female smokers and may influence SMs. Additional research should replicate these observations and explore the implications on smoking cessation outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85031498464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031498464&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2017.10.011

DO - 10.1016/j.addbeh.2017.10.011

M3 - Article

VL - 77

SP - 187

EP - 192

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

ER -